Anglo French Drugs & Industries forays into fertility segment with new supplements

Introducing a new product range with supplements for both men and women

Anglo French Drugs & Industries has entered into the fertility space with the launch of the LYBER Range.

The products that have been launched are LYBER-M: A male fertility supplement which uses a combination of antioxidants to improve sperm motility, count, quality and DNA preservation; LYBER-PCO: A PCOS treatments drug which also helps women in conceiving a child and can be used for restoring ovulation processes. It also contains Vitamin D and chromium

LYBER+ is a herbal formulation of Shilajit 250 mg along with other power-packed phytomedicines (i.e. Safed Musli, Ashwagandha, Kaunch Beej, Gokshura and Shatavari) which helps in increasing stamina, strength, energy and relieves stress. 

The product range has received confirmation from the Food Safety and Standards Authority of India (FSSAI) and the Ayurvedic Authority respectively. 

Abhay Kanoria, Chairman and Managing Director, Anglo French Drugs & Industries Limited said, “Over the years pharma industry has progressed at an exceptional pace in the fertility segment. Men and women have been facing a lot of fertility problems due to the fast-paced lifestyle they have been living over a period of time. Today fertility is one major issue that a lot of couples are dealing with in their everyday life.”

Read Previous

Shilpa Vaid takes charge as CHRO for Diageo India

Read Next

Scientists develop new healthy vegetable snack

Leave a Reply